Anonymous
Guest
Anonymous
Guest
Got a call as well. Sure hope this drug teams up with the Gilead product. First company to market is pretty much going to clean house.
It seems very, very quiet. Has anyone heard anything????
Having second round of interviews soon, looks like a good opportunity. I've pulled $190 a year for the past 4 years with base and bonus in HCV, will be interesting to see what the earning potential is. Selling Simponi will help expand experience in other areas of GI.
Word is out that Gilead was interviewing pretty aggressively in the south east this past week and that offers will be going out soon.
Having second round of interviews soon, looks like a good opportunity. I've pulled $190 a year for the past 4 years with base and bonus in HCV, will be interesting to see what the earning potential is. Selling Simponi will help expand experience in other areas of GI.
Word is out that Gilead was interviewing pretty aggressively in the south east this past week and that offers will be going out soon.
Having second round of interviews soon, looks like a good opportunity. I've pulled $190 a year for the past 4 years with base and bonus in HCV, will be interesting to see what the earning potential is. Selling Simponi will help expand experience in other areas of GI.
Word is out that Gilead was interviewing pretty aggressively in the south east this past week and that offers will be going out soon.
I'd like to join a first class co like Merck. Their leadership has created a winning culture which is why they are the #1 HCV co.
So funny......their final demise will hit when simeprevir and sofosbuvir hit the market, that is unless they price boceprevir at 50 cents on the dollar and throw in Pegintron. Who the hell would hire one of their HCV reps?
Only Merck is customer centric but you wouldn't understand that would you?